About Comirnaty, a BioNTech and Pfizer vaccine to protect against COVID-19 in individuals 65 years & older or 5-64 years of age at high risk for severe COVID-19
Check eligibility and schedule a COVID-19 vaccine in minutes.
About the Updated Formula of COMIRNATY
An updated formula of COMIRNATY is designed to help protect against more recently circulating strains that cause COVID-19.
Updated formulas of COMIRNATY are made using the same process as previous formulas, with the difference only in the mRNA, which encodes the viral spike protein.
How COMIRNATY Works
COMIRNATY helps train your immune system.
After vaccination, it works to teach the body to recognize and help fight the virus that causes COVID-19 without you ever having been exposed to it.
COMIRNATY does not contain SARS-CoV-2, the virus that causes COVID-19. COMIRNATY cannot give you COVID-19.
1.
2.
3.
COVID-19 Vaccine Costs
Most people with insurance should continue to pay $0 out of pocket for COMIRNATY, a COVID-19 vaccine by BioNTech & Pfizer.
Pfizer’s Patient Assistance Programs
Eligible* individuals 65 years of age and older and individuals 5 to 64 with an underlying medical condition without insurance can receive COMIRNATY at no cost:
- Through select federally qualified health centers, hospitals, and free clinics participating in Pfizer’s Institutional Patient Assistance Program (IPAP)
Please check PfizerRxPathways.com for the latest information.
IMPORTANT: Always call the vaccination location to ensure they have COMIRNATY in stock prior to visiting.
Vaccines for Children Program
If you do not have insurance or are enrolled in Medicaid, the Vaccines for Children (VFC) Program may be able to help. The VFC is a government-funded program that provides vaccines at no cost to children 18 years of age and younger who might not otherwise be vaccinated because they are not able to pay. The vaccines are given for free, but there might be other costs, such as payment for the visit or other services.
Learn more about the VFC Program and eligibility here.
Learn More About COVID‑19
